GGrantIndex
← Leaderboards

Robert T Abraham

Duke University

$4,888,060
Attributed
$4,888,060
Total exposure
6
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $232.4K · FY200508
$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08

Funding mix

By agency

NIH$14,295,716 · 7

By mechanism

P30$9,836,073 · 2
R01$3,606,454 · 3
U19$853,189 · 2

Top collaborators

No co-investigators on record.

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Enzyme Activity

Research focus

Enzyme ActivityBiological Signal TransductionPhosphorylationTissue /Cell CultureEnzyme MechanismSirolimusCell CycleCell LineAntineoplasticsNeoplastic CellTranslation FactorEnzyme InhibitorsGrowth InhibitorsDrug Screening /EvaluationCell TransformationNeoplasm /Cancer GeneticsNeoplasm /Cancer PharmacologyPhosphatidylinositol 3 KinaseCell Growth RegulationBioassayCell ProliferationDna RepairCombinatorial ChemistryDrug Discovery /Isolation

Grant awards (26)

Developmental Pilot Project 2$151,170
P30 · FY2008 · CA · contact PI
Developmental Pilot Project 2$140,274
P30 · FY2007 · CA · contact PI
Developmental Pilot Project 2$47,014
P30 · FY2006 · CA · contact PI
KINASE TARGETS IN HYPOXIC CANCER CELLS$186,754
U19 · FY2005 · CA
Developmental Pilot Project 2$45,644
P30 · FY2005 · CA
CANCER CENTER SUPPORT GRANT$3,400,001
P30 · FY2004 · CA
Roles of ATM and ATR Kinases in DNA Damage Responses$396,495
R01 · FY2004 · CA
Cellular Pharmacology of Rapamycin$336,000
R01 · FY2004 · CA
Developmental Pilot Project 2$44,315
P30 · FY2004 · CA
CANCER CENTER SUPPORT GRANT$3,043,791
P30 · FY2003 · CA
Roles of ATM and ATR Kinases in DNA Damage Responses$396,495
R01 · FY2003 · CA
SIGNAL TRANSDUCTION FROM THE T CELL ANTIGEN RECEPTOR$348,480
R01 · FY2003 · GM
Cellular Pharmacology of Rapamycin$336,000
R01 · FY2003 · CA
CANCER CENTER SUPPORT GRANT$2,963,864
P30 · FY2002 · CA
Roles of ATM and ATR Kinases in DNA Damage Responses$396,495
R01 · FY2002 · CA
SIGNAL TRANSDUCTION FROM THE T CELL ANTIGEN RECEPTOR$348,480
R01 · FY2002 · GM
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY$250,404
U19 · FY2002 · CA
SIGNAL TRANSDUCTION FROM THE T CELL ANTIGEN RECEPTOR$348,480
R01 · FY2001 · GM
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY$250,404
U19 · FY2001 · CA
CELLULAR PHARMACOLOGY OF RAPAMYCIN$147,767
R01 · FY2001 · CA
CELLULAR PHARMACOLOGY OF RAPAMYCIN$69,643
R01 · FY2001 · CA
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY$0
U19 · FY2001 · CA
SIGNAL TRANSDUCTION FROM THE T CELL ANTIGEN RECEPTOR$271,040
R01 · FY2000 · GM
CELLULAR PHARMACOLOGY OF RAPAMYCIN$211,079
R01 · FY2000 · CA
CELL CYCLE TARGETS FOR ANTICANCER DRUGS$165,627
U19 · FY2000 · CA
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY$0
U19 · FY2000 · CA